Zongjuan Li
Overview
Explore the profile of Zongjuan Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song X, Li Z, Wang X, Du H, Jia Y, Chen S, et al.
Sci Bull (Beijing)
. 2024 Nov;
70(1):47-50.
PMID: 39580243
No abstract available.
2.
Zhang Y, Hong W, Zheng D, Li Z, Hu Y, Chen Y, et al.
Clin Exp Immunol
. 2024 Aug;
218(2):188-198.
PMID: 39185713
Preclinical data suggest that type I interferon (IFN) responsiveness is essential for the antitumor effects of radiotherapy (RT). However, its clinical value remains unclear. This study aimed to explore this...
3.
Hong W, Zhang Y, Wang S, Li Z, Zheng D, Hsu S, et al.
Adv Sci (Weinh)
. 2024 Feb;
11(16):e2308009.
PMID: 38381090
Many patients with hepatocellular carcinoma (HCC) respond poorly to radiotherapy despite remarkable advances in treatment. A deeper insight into the mechanism of sensitivity of HCC to this therapy is urgently...
4.
Chen Z, Xiao Z, Tian W, Li Z, Wu T
Iran J Public Health
. 2023 Aug;
52(7):1476-1486.
PMID: 37593506
Background: The drug resistance of chemotherapeutic agents leads to unsatisfactory survival rates for cervical cancer (CC) patients. We aimed to explore the effect of FOXP2 on the sensitivity of CC...
5.
Zhang Y, Li Z, Hong W, Hsu S, Wang B, Zeng Z, et al.
Int J Radiat Oncol Biol Phys
. 2023 May;
117(4):928-941.
PMID: 37230431
Purpose: Radiation therapy (RT) is indispensable for managing thoracic carcinomas. However, its application is limited by radiation-induced lung injury (RILI), one of the most common and fatal complications of thoracic...
6.
Zhang Y, Li Z, Xiao H, Li Z, He J, Du S, et al.
Ann Transl Med
. 2023 Jan;
10(23):1264.
PMID: 36618794
Background: Radiation pneumonitis (RP) is a type of toxicity commonly associated with thoracic radiation therapy. We sought to establish a random forest (RF) model and evaluate its ability to predict...
7.
Zhang Y, Li Z, Chen Y, Yang P, Hu Y, Zeng Z, et al.
Transl Oncol
. 2022 Sep;
26:101537.
PMID: 36115075
Background: Our preclinical research reveals that radiotherapy (RT) promoted PD-L1 upregulation in tumor tissues and that higher PD-L1 after RT worsened the prognosis through immunosuppression. We sought to validate our...
8.
Li Z, Zhang Y, Hong W, Wang B, Chen Y, Yang P, et al.
Gut Microbes
. 2022 Sep;
14(1):2119055.
PMID: 36093568
Studies of the gut-liver axis have enhanced our understanding of the pathophysiology of various liver diseases and the mechanisms underlying the regulation of the effectiveness of therapies. Radiotherapy (RT) is...
9.
Zhang Y, Li Z, Chen Y, Xiao H, Zhou Y, Du S, et al.
J Oncol
. 2021 Dec;
2021:2721261.
PMID: 34887921
Objective: To evaluate the efficacy and toxicity of hypofractionated radiotherapy (hypo-RT) for stage III non-small-cell lung cancer (NSCLC) in the Chinese population. Methods: Eighty-six stage III NSCLC patients who received...
10.
Zhang Y, Li Z, Chen Y, Tan L, Zeng Z, Ding J, et al.
Front Oncol
. 2021 Aug;
11:704220.
PMID: 34367988
Surgery remains cornerstone for the management of thymoma. Complete surgical resection (R0), is recognized as the constant and significant factor for prognosis. However, in locally advanced (Masaoka-Koga stages III-IVa) thymomas,...